arrow
A

Adalsteinn Gunnlaugsson

Lund University
H指数:21
被引数:2,274

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metal artifact reduction for 3 T MRI-only prostate radiotherapy in patients with hip prostheses: impact on target definition, synthetic CT generation, dose calculation, and fiducial marker identification

金属伪影减少对3 T MRI-only前列腺放疗中髋关节假体患者的影响:对靶区定义、合成CT生成、剂量计算和标记物识别的影响

2026-09-070
OAAI
Metastasis-directed SBRT for oligometastatic hormone sensitive prostate cancer (METRO): protocol for a prospective randomised phase III trial, NCT04983095

针对寡转移性激素敏感型前列腺癌的定向SBRT治疗(METRO):一项前瞻性随机III期试验方案,NCT04983095

2026-03-250
OAAI
Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer (HYPO-RT-PC): 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial

超分割与常规分割放疗治疗局限性前列腺癌 (hypo-rt-pc): 一项开放标签,随机,3期,非劣效性试验的10年结果

2026-02-050
PRE
Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC

关于局部前列腺癌随机、非劣效性、III期试验HYPO-RT-PC中,超短分割放疗与常规分割放疗后10年泌尿生殖系统和胃肠道发病率的常规收集健康数据

2025-12-110
OAAI
LUND-PROBE - LUND Prostate Radiotherapy Open Benchmarking and Evaluation dataset

LUND-PROBE - LUND前列腺放射治疗开放基准测试与评估数据集

2025-04-110
OA
Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography/multiparametric magnetic resonance imaging
2024-07-012
OAAI
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

超分割与常规分割放疗治疗前列腺癌: hypo-rt-pc随机,非劣效性,3期试验的5年结果

LANCET
IF88.5
2019-08-01575
PREAI